Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Lotharius

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Experimental Neurology|May 5, 2005
Oxidative stress and inflammation in Parkinson's disease: is there a causal link?Andreas Hald, Julie Lotharius
Human Molecular Genetics|September 28, 2002
Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's diseaseJulie Lotharius, Patrik Brundin
Nature Reviews. Neuroscience|December 4, 2002
Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synucleinJulie Lotharius, Patrik Brundin
Lakartidningen|May 13, 2003
[Free radicals and ailing proteins--the culprits behind Parkinson disease?]Ruben Smith, Julie Lotharius, Patrik Brundin
Sub-Cellular Biochemistry|July 7, 2007
Inflammation in Parkinson's disease: causative or epiphenomenal?Andreas Hald, Johan Van Beek, Julie Lotharius
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Specific modulation of astrocyte inflammation by inhibition of mixed lineage kinases with CEP-1347Jeppe Falsig, Peter Pörzgen, Julie Lotharius, et al.
Neurobiology of Disease|September 19, 2003
Targeted expression of BCL-2 attenuates MPP+ but not 6-OHDA induced cell death in dopaminergic neuronsKaren L O'Malley, Jian Liu, Julie Lotharius, et al.
Future Medicinal Chemistry|September 2, 2011
Challenges in antimalarial drug discoveryJeremy N Burrows, Didier Leroy, Julie Lotharius, et al.
Brain Research|November 22, 2007
Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levelsSandra Vergo, Jens Leander Johansen, Marcel Leist, et al.
The American Journal of Tropical Medicine and Hygiene|December 2, 2010
A randomized, double-blind, placebo-controlled study to investigate the safety, tolerability, and pharmacokinetics of single enantiomer (+)-mefloquine compared with racemic mefloquine in healthy personsRobert Tansley, Julie Lotharius, Anthony Priestley, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Experimental Neurology|May 5, 2005
Oxidative stress and inflammation in Parkinson's disease: is there a causal link?Andreas Hald, Julie Lotharius
Human Molecular Genetics|September 28, 2002
Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's diseaseJulie Lotharius, Patrik Brundin
Nature Reviews. Neuroscience|December 4, 2002
Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synucleinJulie Lotharius, Patrik Brundin
Lakartidningen|May 13, 2003
[Free radicals and ailing proteins--the culprits behind Parkinson disease?]Ruben Smith, Julie Lotharius, Patrik Brundin
Sub-Cellular Biochemistry|July 7, 2007
Inflammation in Parkinson's disease: causative or epiphenomenal?Andreas Hald, Johan Van Beek, Julie Lotharius
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Specific modulation of astrocyte inflammation by inhibition of mixed lineage kinases with CEP-1347Jeppe Falsig, Peter Pörzgen, Julie Lotharius, et al.
Neurobiology of Disease|September 19, 2003
Targeted expression of BCL-2 attenuates MPP+ but not 6-OHDA induced cell death in dopaminergic neuronsKaren L O'Malley, Jian Liu, Julie Lotharius, et al.
Future Medicinal Chemistry|September 2, 2011
Challenges in antimalarial drug discoveryJeremy N Burrows, Didier Leroy, Julie Lotharius, et al.
Brain Research|November 22, 2007
Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levelsSandra Vergo, Jens Leander Johansen, Marcel Leist, et al.
The American Journal of Tropical Medicine and Hygiene|December 2, 2010
A randomized, double-blind, placebo-controlled study to investigate the safety, tolerability, and pharmacokinetics of single enantiomer (+)-mefloquine compared with racemic mefloquine in healthy personsRobert Tansley, Julie Lotharius, Anthony Priestley, et al.
Pageof 2